Thrombin
Top View
- Evaluation of a Blood Coagulation Factor IX Variant That Functions Independently of Factor VIII As an Alternative Treatment for Hemophilia A
- The Structural Basis for Complement Inhibition by Gigastasin, a Protease Inhibitor from the Giant Amazon Leech
- Coagulation Factor Xa (Arachidonic Acid/Factor V Antibody/Thrombin) A
- Kallikrein Directly Interacts with and Activates Factor IX, Resulting in Thrombin Generation and Fibrin Formation Independent of Factor XI
- Activated Human Protein C Prevents Thrombin-Induced Thromboembolism in Mice. Evidence That Activated Protein C Reduces Intravasc
- The Plasma Kallikrein-Kinin System Counterbalances the Renin- Angiotensin System
- Comparative Pharmacologic Studies on Synthetic and Recombinant Inhibitors of Thrombin
- Coagulation Factor Products
- Canonical and Non-Canonical Reelin Signaling
- Thrombin-Like Enzymes in Snake Venoms
- Oxidative Stress and the Regulation of Complement Activation in Human Glaucoma
- For Furin: Application As an Antipathogenic Agent
- Targeting Complement Component 5A Promotes Vascular Integrity and Limits Airway Remodeling
- Antithrombotic Effects of Thrombin-Induced Activation of Endogenous Protein C in Primates
- A Dissertation Entitled Role of Complement Regulatory Proteins
- Functional Characterization of Recombinant Batroxobin, a Snake Venom Thrombin-Like Enzyme, Expressed from Pichia Pastoris
- Reelin Modulates Plcγ2 Phosphorylation Upon Platelet
- Batroxobin Maranhao